Current concepts in the management of movement disorders.
D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001264:Athetosis / Q000628:therapy; D001479:Basal Ganglia / Q000378:metabolism; D001480:Basal Ganglia Diseases / Q000378:metabolism / Q000628:therapy; D002819:Chorea / Q000175:diagnosis / Q000188:drug therapy; D004298:Dopamine / Q000009:adverse effects / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D004421:Dystonia / Q000628:therapy; D006801:Humans; D007926:Lesch-Nyhan Syndrome / Q000628:therapy; D009069:Movement Disorders / Q000628:therapy*; D018377:Neurotransmitter Agents / Q000378:metabolism; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D019966:Substance-Related Disorders / Q000209:etiology; D014103:Torticollis / Q000628:therapy; D005879:Tourette Syndrome / Q000628:therapy; D014202:Tremor / Q000628:therapy
D000978:Antiparkinson Agents; D018377:Neurotransmitter Agents; D004298:Dopamine